Ohio Public Employees Retirement System (OPERS)’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,820
Closed -$45K 1982
2023
Q2
$45K Buy
+1,820
New +$47.4K ﹤0.01% 1581
2023
Q1
Sell
-1,579
Closed -$111K 2008
2022
Q4
$111K Sell
1,579
-358
-18% -$26.5K ﹤0.01% 1472
2022
Q3
$167K Buy
+1,937
New +$188K ﹤0.01% 1493
2020
Q1
Sell
-440
Closed -$18K 1905
2019
Q4
$18K Hold
440
﹤0.01% 1849
2019
Q3
$14K Buy
+440
New +$21.2K ﹤0.01% 1942

Other funds holding KZR

Ohio Public Employees Retirement System (OPERS)'s KZR Position: Q3 2023 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Kezar Life Sciences (KZR) in Q3 2023, closing a stake of 1,820 shares — an estimated $45K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in KZR in Q3 2019 and held it in 5 quarters. The position peaked at $167K in Q3 2022. 82 funds tracked by Wall St. Rank hold KZR as of Q3 2023.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Kezar Life Sciences position as of Q3 2023 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 1,820 Kezar Life Sciences shares in Q3 2023, an estimated $45K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Kezar Life Sciences in Q3 2019 and held it in 5 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Kezar Life Sciences position peaked at $167K in Q3 2022.
  • 82 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2023.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2023, filed 15 Nov 2023.